Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yellapu Nanda Kumar is active.

Publication


Featured researches published by Yellapu Nanda Kumar.


Antiviral Research | 2012

Identification of substituted (3, 2-a) pyrimidines as selective antiviral agents: Molecular modeling study

Kilaru Ravendra Babu; Valasani Koteswara Rao; Yellapu Nanda Kumar; Kishore Polireddy; Kadiam C. Venkata Subbaiah; Matcha Bhaskar; Valluru Lokanatha; Chamarthi Naga Raju

A series of novel substituted dihydropyrimidine and 5H-thiazolo [3, 2-a] pyrimidine derivatives were designed and synthesized as a potential target to discover drugs fighting against the viral diseases. The main objective of the present work is to carry out the QSAR studies for all the series of the compounds starting from 4a to 6j to find out their molecular descriptors and predict the biological properties. All of them are showing the best QSAR descriptors, hence chosen for the prediction of anti-viral activity against Newcastle disease virus (NDV). Initially their inhibitory activity was predicted by molecular docking of these compounds against haemaglutinin-neuraminidase (HN) protein using molecular operating environment (MOE) software. Based on the best affinity and highest docking scores 4b, 5b and 6b were assayed in vivo on NDV infected chicks and it was found that there is significant improvement in the survival of the chicks with the treatment (P<0.05). 4b and 6b showed better curative effect than 5b at the dose concentration of 40 mg/kg body weight of chicks. The results from molecular docking study and biological assays can be inferred to consider these molecules as potential antiviral drugs.


Indian Journal of Pharmaceutical Sciences | 2009

Antimicrobial evaluation of mangiferin analogues

S. K. Singh; Yellapu Nanda Kumar; S Sadish Kumar; Vishakha Sharma; Kamal Dua; Abdul Samad

The naturally occurring xanthone glycoside mangiferin has been isolated by column chromatography from the ethanol extract of stem bark of Mangifera indica. Mangiferin was further converted to 5-(N-phenylaminomethyleno)mangiferin, 5-(N-p-chlorophenylaminomethyleno) mangiferin, 5-(N-2-methylphenylaminomethyleno) mangiferin, 5-(N-p-methoxyphenylaminomethyleno) mangiferin, 5-(N, N-diphenylaminomethyleno) mangiferin, 5-(N--napthylaminomethyleno) mangiferin and 5-(N-4-methylphenylaminomethyleno) mangiferin. Mangiferin and its analogues were characterized by melting point and Rf value determination and through spectral technique like UV, IR, and NMR spectral analysis. The synthesized compounds were screened for antimicrobial activity.


Natural Product Research | 2010

New antifungal steroids from Turbinaria conoides (J. Agardh) Kutzing

S. Sadish Kumar; Yellapu Nanda Kumar; Mujahid Khan; V.K. Gupta

Two new steroids 3,6,17-trihydroxy-stigmasta-4,7,24(28)-triene (1) and 14,15,18,20-diepoxyturbinarin (3), together with a known compound, fucosterol (2), were isolated from the cyclohexane extract of Turbinaria conoides. The structures were elucidated on the basis of spectroscopic evidence. The isolated compounds were screened against a panel of microorganisms. Minimum inhibitory concentrations (MICs) were determined by the standard broth dilution method. Compounds 1–3 exhibited moderate antibacterial activity against the tested bacteria and inhibited the fungal growth with MIC values ranging from 2 to 16 µg mL−1. Compound 3 was found to be most potent against Aspergillus niger, with an MIC value of 2.0 µg mL−1. The isolation of antifungal compounds from T. conoides is reported for the first time. These results suggested that 14,15,18,20-diepoxyturbinarin (3) could be developed as a new lead antifungal agent.


Drug Design Development and Therapy | 2015

Modeling, molecular dynamics, and docking assessment of transcription factor rho: a potential drug target in Brucella melitensis 16M

Jangampalli Adi Pradeepkiran; Konidala Kranthi Kumar; Yellapu Nanda Kumar; Matcha Bhaskar

The zoonotic disease brucellosis, a chronic condition in humans affecting renal and cardiac systems and causing osteoarthritis, is caused by Brucella, a genus of Gram-negative, facultative, intracellular pathogens. The mode of transmission and the virulence of the pathogens are still enigmatic. Transcription regulatory elements, such as rho proteins, play an important role in the termination of transcription and/or the selection of genes in Brucella. Adverse effects of the transcription inhibitors play a key role in the non-successive transcription challenges faced by the pathogens. In the investigation presented here, we computationally predicted the transcription termination factor rho (TtFRho) inhibitors against Brucella melitensis 16M via a structure-based method. In view the unknown nature of its crystal structure, we constructed a robust three-dimensional homology model of TtFRho’s structure by comparative modeling with the crystal structure of the Escherichia coli TtFRho (Protein Data Bank ID: 1PVO) as a template in MODELLER (v 9.10). The modeled structure was optimized by applying a molecular dynamics simulation for 2 ns with the CHARMM (Chemistry at HARvard Macromolecular Mechanics) 27 force field in NAMD (NAnoscale Molecular Dynamics program; v 2.9) and then evaluated by calculating the stereochemical quality of the protein. The flexible docking for the interaction phenomenon of the template consists of ligand-related inhibitor molecules from the ZINC (ZINC Is Not Commercial) database using a structure-based virtual screening strategy against minimized TtFRho. Docking simulations revealed two inhibitors compounds – ZINC24934545 and ZINC72319544 – that showed high binding affinity among 2,829 drug analogs that bind with key active-site residues; these residues are considered for protein-ligand binding and unbinding pathways via steered molecular dynamics simulations. Arg215 in the model plays an important role in the stability of the protein-ligand complex via a hydrogen bonding interaction by aromatic-π contacts, and the ADMET (absorption, distribution, metabolism, and excretion) analysis of best leads indicate nontoxic in nature with good potential for drug development.


Bioinformation | 2012

In silico model of DSF synthase RpfF protein from Xanthomonas oryzae pv. Oryzae: a novel target for bacterial blight of rice disease

Vidavaluru Sravani Reddy; Yellapu Nanda Kumar; Aminedi Raghavendra; Gopal Sowjenya; Suman Kumar; Guggulla Ramyasree; Gottiprolu Rajarami Reddy

Background: Rice plant diseases play a major role as biological constraints on production. One of such rice disease is bacterial leaf blight, caused by Xanthomonas oryzae pv. Oryzae (Xoo). The diffusible signal factor (DSF) synthesized by Xoo has a major role in virulence to rice plant. The DSF synthase RpfF protein, which is related to crotonase superfamily is responsible for the maintaining concentration of DSF. DSF-dependent quorum sensing (QS) system adopts protein- protein interaction mechanism to auto regulates the production of DSF. The antibacterial activity of pesticides against Xoo has not yet been completely understood. Three dimensional structure of RpfF protein was predicted using homology modeling method by MODELLER 9V9 software, SWISS MODEL and GENO3D online tools and structures were validated by Ramachandran plot, TM-Score and RMSD. 3D structure of RpfF (accession number AAL06345) was predicted using DSF synthase of Xanthomonas campestris pv. campestris (Xcc) (PDB ID: 3M6M) as a template. The stereo chemical check reveals the structure developed from the modeller was the best one and the potential ligand binding sites were identified by CASTp Server. The predicted RpfF model provides insight into its structure, active sites and aid in the development of novel inhibitors to control bacterial leaf blight in rice plant. DSF synthase RpfF protein could be used as a novel target to control infection


Bioinformation | 2012

Comparison and correlation of binding mode of ATP in the kinase domains of Hexokinase family.

Yellapu Nanda Kumar; Pasupuleti Santhosh Kumar; Gopal Sowjenya; Valasani Koteswara Rao; Sthanikam Yeswanth; Uppu Venkateswara Prasad; Jangampalli Adi Pradeepkiran; P. V. G. K. Sarma; Matcha Bhaskar

Hexokinases (HKs) are the enzymes that catalyses the ATP dependent phosphorylation of Hexose sugars to Hexose-6-Phosphate (Hex-6-P). There exist four different forms of HKs namely HK-I, HK-II, HK-III and HK-IV and all of them share a common ATP binding site core surrounded by more variable sequence that determine substrate affinities. Although they share a common binding site but they differ in their kinetic functions, hence the present study is aimed to analyze the binding mode of ATP. The analysis revealed that the four ATP binding domains are showing 13 identical, 7 similar and 6 dissimilar residues with similar structural conformation. Molecular docking of ATP into the kinase domains using Molecular Operating Environment (MOE) soft ware tool clearly showed the variation in the binding mode of ATP with variable docking scores. This probably explains the variable phosphorylation rates among hexokinases family.


Journal of Pharmacy and Bioallied Sciences | 2014

In silico designing and molecular docking of a potent analog against Staphylococcus aureus porphobilinogen synthase

Pasupuleti Santhosh Kumar; Yellapu Nanda Kumar; Uppu Venkateswara Prasad; Sthanikam Yeswanth; Vimjam Swarupa; Gopal Sowjenya; Katari Venkatesh; Lokanathan Srikanth; Valasani Koteswara Rao; Potukuchi Venkata Gurunatha Krishna Sarma

Background: The emergence of multidrug-resistant strains of Staphylococcus aureus, there is an urgent need for the development of new antimicrobials which are narrow and pathogen specific. Aim: In this context, the present study is aimed to have a control on the staphylococcal infections by targeting the unique and essential enzyme; porphobilinogen synthase (PBGS) catalyzes the condensation of two molecules of δ-aminolevulinic acid, an essential step in the tetrapyrrole biosynthesis. Hence developing therapeutics targeting PBGS will be the promising choice to control and manage the staphylococcal infections. 4,5-dioxovalerate (DV) is known to inhibit PBGS. Materials and Methods: In view of this, in this study, novel dioxovalerate derivatives (DVDs) molecules were designed so as to inhibit PBGS, a potential target of S. aureus and their inhibitory activity was predicted using molecular docking studies by molecular operating environment. The 3D model of PBGS was constructed using Chlorobium vibrioform (Protein Data Bank 1W1Z) as a template by homology modeling method. Results: The built structure was close to the crystal structure with Z score − 8.97. Molecular docking of DVDs into the S. aureus PBGS active site revealed that they are showing strong interaction forming H-bonds with the active sites of K248 and R217. The ligand–receptor complex of DVD13 showed a best docking score of − 14.4555 kcal/mol among DV and all its analogs while the substrate showed docking score of − 13.0392 kcal/mol showing interactions with S199, K217 indicating that DVD13 can influence structural variations on the enzyme and thereby inhibiting the enzyme. Conclusion: The substrate analog DVD13 is showing significant interactions with active site of PBGS and it may be used as a potent inhibitor to control S. aureus infections.


Indian Journal of Pharmaceutical Sciences | 2014

Comparative structural and functional analysis of staphylococcus aureus glucokinase with other bacterial glucokinases

Pasupuleti Santhosh Kumar; Yellapu Nanda Kumar; Uppu Venkateswara Prasad; Sthanikam Yeswanth; Vimjam Swarupa; D. Vasu; Katari Venkatesh; Lokanathan Srikanth; Valasani Koteswara Rao; Potukuchi Venkata Gurunadha Krishna Sarma

Glucokinase is classified in bacteria based upon having ATP binding site and ‘repressor/open reading frames of unknown function/sugar kinases’ motif, the sequence of glucokinase gene (JN645812) of Staphylococcus aureus ATCC12600 showed presence of ATP binding site and ‘repressor/open reading frames of unknown function/sugar kinases’ motif. We have earlier observed glucokinase of S. aureus has higher affinity towards the substrate compared to other bacterial glucokinase and under anaerobic condition with increased glucose concentration S. aureus exhibited higher rate of biofilm formation. To establish this, 3D structure of glucokinase was built using homology modeling method, the PROCHECK and ProSA-Web analysis indicated this built glucokinase structure was close to the crystal structure. This structure was superimposed with different bacterial glucokinase structures and from the root-mean-square deviation values, it is concluded that S. aureus glucokinase exhibited very close homology with Enterococcus faecalis and Clostridium difficle while with other bacteria it showed high degree of variations both in domain and nondomain regions. Glucose docking results indicated -12.3697 kcal/mol for S. aureus glucokinase compared with other bacterial glucokinase suggesting higher affinity of glucose which correlates with enzyme kinetics and higher rate of biofilm formation.


Bioinformation | 2014

Structural and Functional analysis of Staphylococcus aureus NADP-dependent IDH and its comparison with Bacterial and Human NADPdependent IDH.

Uppu Venkateswara Prasad; Vimjam Swarupa; Sthanikam Yeswanth; Pasupuleti Santhosh Kumar; Easambadi Siva Kumar; Kalikiri Mahesh Kumar Reddy; Yellapu Nanda Kumar; Vangavaragu Jhansi Rani; Abhijit Chaudhary; Potukuchi Venkata Gurunadha Krishna Sarma

Staphylococcus aureus a natural inhabitant of nasopharyngeal tract mainly survives as biofilms and possess complete Krebs cycle which plays major role in its pathogenesis. This TCA cycle is regulated by Isocitrate dehydrogenase (IDH) we have earlier cloned, sequenced (HM067707), expressed and characterized this enzyme from S. aureus ATCC12600. We have observed only one type of IDH in all the strains of S. aureus which dictates the flow of carbon thereby controlling the virulence and biofilm formation, this phenomenon is variable among bacteria. Therefore in the present study comparative structural and functional analysis of IDH was undertaken. As the crystal structure of S. aureus IDH was not available therefore using the deduced amino sequence of complete gene the 3D structure of IDH was built in Modeller 9v8. The PROCHECK and ProSAweb analysis showed the built structure was close to the crystal structure of Bacillus subtilis. This structure when superimposed with other bacterial IDH structures exhibited extensive structural variations as evidenced from the RMSD values correlating with extensive sequential variations. Only 24% sequence identity was observed with both human NADP dependent IDHs (PDB: 1T09 and 1T0L) and the structural comparative studies indicated extensive structural variations with an RMSD values of 14.284Å and 10.073Å respectively. Docking of isocitrate to both human IDHs and S. aureus IDH structures showed docking scores of -11.6169 and -10.973 respectively clearly indicating higher binding affinity of isocitrate to human IDH.


Natural Product Research | 2011

Antihistaminic and antiviral activities of steroids of Turbinaria conoides

S. Sadish Kumar; Yellapu Nanda Kumar; Mujahid Khan; J. Anbu; E. De Clercq

The steroids 3,6,17-trihydroxy-stigmasta-4,7,24(28)-triene (A) and 14,15,18,20-diepoxyturbinarin (B) were isolated from the cyclohexane extract of brown alga, Turbinaria conoides (J. Agardh) Kutzing, and have been reported for their antimicrobial activity by us. In this study, the isolated compounds were evaluated for comprehensive antihistaminic, antiviral and cytotoxicity screening. The antihistaminic study was performed using in vitro standard animal models. Evaluation of the potency (EC50), affinity (pA2) and the maximal response (E max) of the histamine alone and in the presence of the compounds were determined. Antiviral activity and cytotoxicity were performed in Crandell-Rees feline kidney (CRFK) cells by a colorimetric formazan-based MTS assay. No significant antiviral activity or cytotoxicity were observed for the compounds in the CRFK cells. Compound A inhibited the histamine-induced concentration at 20 µg mL−1(p < 0.05). The most significant inhibition (97%) was observed for compound B (p < 0.01) at the same concentration, which was comparable to that of the positive control chlorpheniramine maleate (10 µg mL−1). This potentiality suggests that 14,15,18,20-diepoxyturbinarin (B) can be developed as a new lead antihistaminic agent.

Collaboration


Dive into the Yellapu Nanda Kumar's collaboration.

Top Co-Authors

Avatar

Sthanikam Yeswanth

Sri Venkateswara Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Uppu Venkateswara Prasad

Sri Venkateswara Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Matcha Bhaskar

Sri Venkateswara University

View shared research outputs
Top Co-Authors

Avatar

Vimjam Swarupa

Sri Venkateswara Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Pasupuleti Santhosh Kumar

Sri Venkateswara Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Potukuchi Venkata Gurunadha Krishna Sarma

Sri Venkateswara Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gopal Sowjenya

Sri Venkateswara Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge